Abstract
The diagnosis of Parkinson's disease (PD) is based on a set of clinical assessments that do not provide great accuracy. Although magnetic resonance imaging (MRI) has provided important advances in the diagnosis of many neurological diseases, few biomarkers of PD have been described in order to support its clinical diagnosis. Recently, one single study showed that high field MRI using diff…